Predict your next investment

CytoSeek company logo
HEALTHCARE | Biotechnology

See what CB Insights has to offer

Founded Year



Seed VC - II | Alive

Total Raised


Last Raised

$4.86M | 7 mos ago

About CytoSeek

CytoSeek develops cell membrane augmentation technology to create effective cell therapy for solid tumours. The process involves modifying a patient’s own immune cells to “supercharge” them against cancer cells.

CytoSeek Headquarter Location

Unit DX, St Philips Central Albert Road

Bristol, England, BS2 0XJ,

United Kingdom

Latest CytoSeek News

Science Creates Ventures’ First Investment In CytoSeek

Mar 25, 2021

Osborne Clarke advised Science Creates Ventures on the deal. SCV invested into University of Bristol spin-out CytoSeek, SCV’s first investment since announcing the launch of the fund. CytoSeek is a discovery stage biotech company established to develop next generation cell therapies using artificial membrane-binding protein technology. The start-up has raised £3.5m (led by SCV) and is seeking to get its technology to cancer patients who are currently underserved by existing treatments. SCV has been working closely with CytoSeek since its inception and led a syndicate of new investors that included Parkwalk Advisors, Meltwind, Luminous Ventures and several angel investors in this funding round. The Osborne Clarke team on the CytoSeek investment was led by Partner Matthew Edwards (Picture). Partner Helen Parsonage led on the fund formation, assisted by Partner Erika Jupe on tax.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing CytoSeek

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

CytoSeek is included in 3 Expert Collections, including Biopharmaceuticals.



5,881 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Regenerative Medicine

1,767 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).



3,604 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

CytoSeek Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

CytoSeek Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.